Get started
Author

Wenqiang Yan

Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH
2021 · Yuting Yan, Xiaoqi Qin, et al. · Blood Advances · 24
Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
2024 · Huishou Fan, Bing Wang, et al. · Clinical Cancer Research · 22
PDF
Development and validation of an individualized and weighted Myeloma Prognostic Score System ( MPSS ) in patients with newly diagnosed multiple myeloma
2024 · Xuehan Mao, Wenqiang Yan, et al. · American Journal of Hematology · 20
PDF
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma
2023 · Wenqiang Yan, Jingyu Xu, et al. · Cancer · 15
PDF
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing
2024 · Jian Cui, Xiaoyun Li, et al. · Clinical Cancer Research · 14
PDF
Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
2023 · Wenqiang Yan, Huishou Fan, et al. · Chinese Medical Journal · 11
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
2023 · Jiahui Liu, Wenqiang Yan, et al. · Cancer Research Communications · 10
PDF
Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma
2023 · Jian Cui, Rui Lv, et al. · Haematologica · 10
PDF
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma
2024 · Jian Cui, Yuntong Liu, et al. · Leukemia · 9
PDF
The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteria
2022 · Wenqiang Yan, Huishou Fan, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 9
Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report
2024 · Wenqiang Yan, Yu Xiong, et al. · Journal for ImmunoTherapy of Cancer · 8
PDF
BCMA CAR-T Therapy As First-Line Consolidation Treatment in Transplant-Ineligible Patients with Newly-Diagnosed Multiple Myeloma: An Open Label, Single-Arm, Phase 2 Study (CAREMM-001)
2024 · Wenqiang Yan, Chenxing DU, et al. · Blood · 7
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States
2025 · Jingyu Xu, Meng Shu, et al. · Cancers · 6
PDF
T(11;14) with multiple myeloma: Standard risk survival but slow and poor response
2024 · Yuntong Liu, Jingyu Xu, et al. · Annals of Hematology · 5
The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma
2023 · Huihsou Fan, Wenqiang Yan, et al. · Hematology · 5
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)
2026 · Wenqiang Yan, Chenxing Du, et al. · Journal of Clinical Oncology · 4
Respiratory insufficiency in a Chinese adult with mitochondrial myopathy.
2002 · K C Chang, Y F Mak, et al. · PubMed · 4
BCMA CAR T-cell therapy in newly diagnosed primary plasma cell leukemia ineligible for transplantation: An open label, single-arm, phase 2 study (CAREMM-002)
2025 · Wenqiang Yan, Chenxing Du, et al. · Blood · 3
PDF
Development and validation of a prognostic staging system for primary plasma cell leukemia
2025 · Mengru Tian, Gang An, et al. · Journal of Hematology & Oncology · 3
PDF
Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma
2024 · Jian Cui, Tengteng Yu, et al. · Therapeutic Advances in Medical Oncology · 3
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature review
2023 · Wenqiang Yan, Rui Lv, et al. · Annals of Hematology · 3
[Immunoglobulin M multiple myeloma: a six-case report and literature review].
2021 · W W Yan, H S Fan, et al. · PubMed · 3
BCMA CAR T-Cell Therapy in Newly Diagnosed Primary Plasma Cell Leukemia Ineligible for Transplantation: An Open Label, Single-arm, Phase 2 Study (CAREMM-002)
2025 · Wenqiang Yan, Chenxing Du, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities
2024 · Yuntong Liu, Rui Lv, et al. · Haematologica · 2
PDF
The Specific Transcriptional Signature and Clonal Selection of MGUS-like Profile Predict an Exceptionally Favorable Prognosis in Patients with Newly-Diagnosed Multiple Myeloma
2023 · Wenqiang Yan, Chen Qiu, et al. · Blood · 2
Works count: 141
Citation count: 211
H-index: 9
I10-index: 8
Year
Topic
Type